Genetic thrombophilia in patients with retinal vascular occlusion

International Ophthalmology

Volumn 23, Issue 3, 1999, Pages 155-160

  Greiner, Kathrin ^a   Peetz, Dirk ^a   Winkgen, Andrea ^a   Prellwitz, Winfried ^a   Pfeiffer, Norbert ^a   Hafner, Gerd ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Central retinal vein occlusion; Resistance to activated protein C; Thrombophilia

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TEST; CENTRAL RETINA ARTERY OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; COMPARATIVE STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; GENETIC DISORDER; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN DETERMINATION; RETINA ARTERY OCCLUSION; RETINA BLOOD VESSEL OCCLUSION; RETINA VEIN OCCLUSION; RISK FACTOR; SCREENING; THROMBOPHILIA; VASCULAR DISEASE; ACTIVATED PROTEIN C RESISTANCE; BLOOD; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; PROSPECTIVE STUDY;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; PROTEIN C; PROTEIN S; PROTHROMBIN; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION; THROMBOPHILIA;

EID: 0033301886     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010639332737     Document Type: Article

References (43)

1. Descriptive data analysis: A concept between confirmatory and exploratory data analysis
2. The inherited basis of venous thrombosis
3. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease
4. Hypercoagulability and high lipoprotein(a) levels in patients with central retinal vein occlusion
5. Mutation in blood coagulation factor V associated with resistance to activated protein C
6. Venous thrombosis - The interaction of genes and environment
7. Lack of activated protein C resistance in healthy Hong Kong Chinese blood donors - Correlation with absence of Arg506-Gln mutation of factor V gene
8. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis
9. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C
10. No association of APC resistance with myocardial infarction
11. Does type II diabetes predispose to retinal vein occlusion?
12. Coagulation factor V Leiden mutation may have a racial background
13. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion
14. Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective study
15. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis
16. Factor V and antithrombin gene mutations in patients with idiopathic central retinal vein occlusion
17. Thrombin-antithrombin III complex in acute retinal vein occlusion
18. Modified test for activated protein C resistance
19. Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction
20. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
21. Inherited thrombophilia: Part 1
22. Inherited thrombophilia: Part 2
23. Activated protein C resistance in young adults with central retinal vein occlusion
24. Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C
25. Prevalence of factor V Leiden in young adults with retinal vein occlusion
26. Familial thrombophilia: Genetic risk factors and management
27. Prevalence of phenotypic activated protein C resistance (APCR) in venous thromboembolic patients
28. Incidence and clinical manifestations of activated protein C resistance and factor V Leiden in young patients with venous thromboembolic disease in Spain
29. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
30. 1691 G to A mutation of the factor V gene: No association with thrombosis of the central retinal vein
31. Risk factors for retinal vein occlusions. A case-control study
32. World distribution of factor V Leiden
33. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men
34. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women
35. Resistance to activated protein C and risk of premature myocardial infarction
36. Large-scale screening for factor V Leiden mutation in a north-eastern German population
37. On approximate sample sizes for comparing two independent proportions with the use of Yates' correction
38. The Leiden Thrombophilia Study (LETS)
39. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
40. The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions
41. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: A population controlled study
42. APC-resistenz (Faktor-V-mutation). Klinische Bedeutung, Pathophysiologie und Diagnostik
43. The natural course of central retinal vein occlusion